These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 37332839

  • 21. Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease.
    Whittaker H, Kallis C, Bolton T, Wood A, Walker S, Sheikh A, Brownrigg A, Akbari A, Sterniczuk K, Quint JK, CVD-COVID-UK/COVID-IMPACT Consortium.
    Int J Epidemiol; 2024 Apr 11; 53(3):. PubMed ID: 38850276
    [Abstract] [Full Text] [Related]

  • 22. Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States.
    Kumbhare S, Strange C.
    South Med J; 2018 May 11; 111(5):293-298. PubMed ID: 29767222
    [Abstract] [Full Text] [Related]

  • 23. Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.
    Oshagbemi OA, Keene SJ, Driessen JHM, Jordan R, Wouters EFM, de Boer A, de Vries F, Franssen FME.
    Respir Med; 2018 Nov 11; 144():1-6. PubMed ID: 30366578
    [Abstract] [Full Text] [Related]

  • 24. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW.
    Lancet Respir Med; 2018 Mar 11; 6(3):204-212. PubMed ID: 29331311
    [Abstract] [Full Text] [Related]

  • 25. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD, Poole C, Webster S, Tebboth A, Dickinson S, Gayle A.
    Respir Res; 2018 Apr 11; 19(1):63. PubMed ID: 29642882
    [Abstract] [Full Text] [Related]

  • 26. Impact on survival of combination inhalers in patients with COPD at high risk of cardiovascular events.
    Patel HC, Hayward C, Patel KS, Claggett B, Vazir A, Cowie MR.
    Int J Cardiol; 2020 Feb 01; 300():237-244. PubMed ID: 31813679
    [Abstract] [Full Text] [Related]

  • 27. National trend in the prevalence and mortality of COPD in South Korea from 2008 to 2017.
    Kim SH, Park JE, Yang B, Kim SY, Kim YY, Park JH.
    BMJ Open Respir Res; 2024 Jun 18; 11(1):. PubMed ID: 38897613
    [Abstract] [Full Text] [Related]

  • 28. Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study.
    Whittaker H, Nordon C, Rubino A, Morris T, Xu Y, De Nigris E, Müllerová H, Quint JK.
    Thorax; 2023 Aug 18; 78(8):760-766. PubMed ID: 36316117
    [Abstract] [Full Text] [Related]

  • 29. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease (COPD) in Shahrekord PERSIAN cohort in southwest Iran.
    Kiani FZ, Ahmadi A, Babadi AS, Rouhi H.
    BMC Pulm Med; 2021 Mar 25; 21(1):105. PubMed ID: 33765987
    [Abstract] [Full Text] [Related]

  • 30. Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).
    Kendzerska T, Leung RS, Aaron SD, Ayas N, Sandoz JS, Gershon AS.
    Ann Am Thorac Soc; 2019 Jan 25; 16(1):71-81. PubMed ID: 30372124
    [Abstract] [Full Text] [Related]

  • 31. Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients: a population-based cohort study.
    Chung WS, Lin CL, Kao CH.
    Medicine (Baltimore); 2015 May 25; 94(17):e755. PubMed ID: 25929911
    [Abstract] [Full Text] [Related]

  • 32. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA, Franssen FME, van Kraaij S, Braeken DCW, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Vries F.
    COPD; 2019 Apr 25; 16(2):152-159. PubMed ID: 31117850
    [Abstract] [Full Text] [Related]

  • 33. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
    Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, Van Ganse E.
    Respir Med; 2016 Aug 25; 117():33-9. PubMed ID: 27492511
    [Abstract] [Full Text] [Related]

  • 34. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data.
    Zghebi SS, Steinke DT, Rutter MK, Ashcroft DM.
    BMJ Open; 2020 Jul 01; 10(7):e033866. PubMed ID: 32611677
    [Abstract] [Full Text] [Related]

  • 35. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.
    Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E, She D.
    Ann Epidemiol; 2006 Jan 01; 16(1):63-70. PubMed ID: 16039877
    [Abstract] [Full Text] [Related]

  • 36. Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study.
    Chung WS, Lin CL.
    Respir Med; 2018 Jul 01; 140():6-10. PubMed ID: 29957282
    [Abstract] [Full Text] [Related]

  • 37. Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.
    Whittaker HR, Bloom C, Morgan A, Jarvis D, Kiddle SJ, Quint JK.
    Eur Respir J; 2021 Mar 01; 57(3):. PubMed ID: 32972984
    [Abstract] [Full Text] [Related]

  • 38. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients.
    Simpson CR, Hippisley-Cox J, Sheikh A.
    Br J Gen Pract; 2010 Jul 01; 60(576):277-84. PubMed ID: 20594429
    [Abstract] [Full Text] [Related]

  • 39. Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink.
    Cook S, Schmedt N, Broughton J, Kalra PA, Tomlinson LA, Quint JK.
    BMJ Open; 2023 Mar 07; 13(3):e065927. PubMed ID: 36882249
    [Abstract] [Full Text] [Related]

  • 40. Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data.
    Lenoir A, Whittaker H, Gayle A, Jarvis D, Quint JK.
    Thorax; 2023 Sep 07; 78(9):904-911. PubMed ID: 36423926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.